Description
EXPRESS REPORT: PHARMACY PRIME VENDOR NCO 23 FY17 APR 1, 2016 TO APR 28, 2016 CONTRACT VA797P-12-D-0001
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-04-01+$8,564,037= $8,564,037
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-04-01 | +$8,564,037 | $8,564,037 | EXPRESS REPORT: PHARMACY PRIME VENDOR NCO 23 FY17 APR 1, 2016 TO APR 28, 2016 CONTRACT VA797P-12-D-0001 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI S1RUKWWRYFL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126F0121 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24226P0805 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24026K1010 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,194,619,137 | FY2026 |
| 36C24026K1009 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,191,973,258 | FY2026 |
| 36C26226P1049 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $220,957 | FY2026 |
| 36C24026K1008 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,398,025,092 | FY2026 |
Other recipients under 6505 from 618-MINNEAPOLIS VA MED CTR (00618) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26317J0075 | CSL BEHRING L.L.C. | 618-MINNEAPOLIS VA MED CTR (00618) | $0 | FY2017 |
| VA26317J0064 | CSL BEHRING L.L.C. | 618-MINNEAPOLIS VA MED CTR (00618) | $35,670 | FY2017 |
| VA26317J0003 | EXELIXIS, INC. | 618-MINNEAPOLIS VA MED CTR (00618) | $13,750 | FY2017 |
| VA26317J0007 | ACTELION PHARMACEUTICALS US, INC. | 618-MINNEAPOLIS VA MED CTR (00618) | $24,514 | FY2017 |
| VA26317J0009 | EISAI INC. | 618-MINNEAPOLIS VA MED CTR (00618) | $20,882 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26317E0866_3600_VA797P12D0001_3600 · retrieved 2026-09-26.